An expression system for recombinant conger eel galectins, congerins I and II, were constructed using the pTV 118N plasmid vector and Escherichia coli. Recombinant congerins I and II could be obtained in the soluble active form with high quantitative yield. Mutation of codons for Val and Leu located in the N-terminal region of Con I increased the expression e‹ciency. Puriˆcation of recombinant proteins were done by only two chromatographical steps from E. coli extract. The puriˆed recombinant congerins were found to be almost the same as the native ones except for the acetyl group at the N-terminus; that is, they showed the same structures and carbohydrate binding activities, suggesting that Nterminal acetyl groups of congerins were not signiˆcant for activity.
Congerins I and II (Con I and II) are lectins isolated from skin mucus of the conger eel, 1) which belong to the proto-type galectin family. Proto-type galectin is characterized by (1) having one carbohydrate recognition domain (CRD) with an a‹nity for bgalactosides in a subunit, (2) sharing certain conserved primary sequence elements, and (3) posttranslational modiˆcation of the N-terminal amino acid (e.g. N-acetylation).
2) Congerins have no cysteine residue, diŠering from other galectins which include six cysteine residues in a subunit. Con I and II are dimers composed of two identical subunits of 136 and 135 amino acid residues, respectively. They show 48z sequence identity, and diŠerent molecular properties such as pH and temperature dependencies for hemagglutinating activities and binding speciˆci-ties for lactose derivatives.
3) The X-ray crystal structure of Con I conjugated with lactose indicated that the dimerization manner of Con I was diŠerent from those of known mammalian galectins. 4) The Con I subunits dimerized by forming a domain-swapping structure in the N-terminal regions of the subunits. Furthermore, we suggested the accelerating evolution of Con I and II by comparing the nucleotide sequences of their cDNAs, and the accelerated evolution is compatible with the presence of galectins with diverse molecular properties. 5) Congerins, like other galectins, are apparent cytosolic proteins that lack any signal sequence, although they localize in the extracellular matrix. The secretory pathway of this intriguing lectin family is not yet understood.
The multiple isoprotein system consisting of diŠer-ent active forms such as Con I and II will provide useful and powerful tools for understanding the structure-activity relationships of galectins through the synthesis of a variety of mutant proteins by means of in vitro mutagenesis techniques and directed evolution methods. 6) In addition, congerins are suitable for expression experiments because they lack free cysteine residues which cause the oxidation loss of the carbohydrate binding activity in mammalian galectins.
In this paper, we describe the high-level expression of recombinant Con I and II in E. coli, and the characterization of the proteins compared with the native ones.
The expression plasmids termed pTV-Con I and pTV-Con II were constructed to produce recombinant congerin I (rCon I) and congerin II (rCon II) by introducing the cDNA fragments encoding Con I and II into the expression plasmid vector pTV118N (Takara Shuzo Co., Kyoto, Japan), respectively, at the NcoI (CAECATGG) which includes the initiation codon at 5? upstream of the multi-cloning site. To introduce the BspHI site (TAECATGA) at the N-terminus of each congerin's cDNA for ligation with the vector at the Nco I site, PCR was done using 5? primers, 5?-ACC AAT GCC ATC ATG AGT GGA G-3? for Con I and 5?-ACC TGC TGC CAT CAT GAG TGA T-3? for Con II, respectively. Three-step PCR for site-directed mutagenesis 7) was done because one BspHI site existed in the Con I internal sequence at the 201st position, which required a mutation without amino acid change. Furthermore, the codons of Leu4 (CTT) and Val6 (GTC) of Con I were mutated to CTA and GTT, respectively, in order to increase the expression e‹ciency of Con I. After digestion with BspHI and PstI (Takara Shuzo Co.), the fragments encoding mutated congerin DNAs were puriˆed and cloned into the pTV118N vector at NcoI and PstI sites, respectively, resulting in pTV-Con I and pTV-Con II. The nucleotide sequences of pTV-Con I and pTV-Con II were conˆrmed by the dideoxy sequencing method. The bacterial host used for expression of recombinant congerins was E. coli JM109 strain. Bacteria culture was done in 1 l of 2×YT medium containing ampicillin (50 mg W l), which was inoculated with 1 ml of overnight culture from a single transformed colony of pTV-Con I or pTV-Con II, and was grown at 379 C. The culture was induced by the addition of 1 mM isopropyl-D-thiogalactoside (IPTG) when the cell density had reached OD600＝0.5¿0.6, and incubated for another 10 h at 379 C. Cells were harvested by centrifugation at 11,000 rpm for 20 min. After the cells were washed 3 times with 50 mM Tris-HCl (pH 7.5), the pellets were suspended in ice-cold extraction buŠer (0.25 mM phenylmethyl sulfonyl ‰uoride, 10 mM EDTA, 50 mM Tris-HCl (pH 7.5)) and sonicated by an ultrasonic disruptor UD-20 (TOMY Seiko Co., Japan). After centrifugation at 15,000 rpm for 30 min at 49 C, the supernatant containing recombinant congerin was collected. The recombinant congerins were further puriˆed by the a‹nity chromatography on a HCl-treated Sepharose 6B column (5×12 cm), which was prepared by partial digestion with boiled 1.0 M HCl, and by successive anion exchange chromatography on a Hi-Trap Q column (5 ml, Amersham-Pharmacia, Uppsala, Sweden) equilibrated with 50 mM Tris-HCl (pH 7.5), and eluted by a gradient of 0 M to 0.5 M NaCl in 50 mM Tris-HCl (pH 7.5). The purity of recombinant congerins was conˆrmed by SDS-PAGE and Western blotting using anti-Con I and anti-Con II polyclonal antibodies.
In order to study the structure-activity relationship of galectins using recombinant Con I and II, expression plasmids pTV-Con I and pTV-Con II were constructed by PCR techniques using cDNAs encoding Con I and II as templates, respectively. For introducing the Con I cDNA at BspHI site of the vector, the internal BspHI site at the 201st position of Con I was mutated by the 3-step PCR method 7) with some modiˆcations. rCon I and rCon II were expressed in E. coli strain JM109 transformed by pTV-Con I and pTV-Con II, respectively. The amount of expressed rCon I and rConII increased in proportion to the concentration of IPTG between 0.1 mM and 1 mM (data not shown). However, a signiˆcant diŠerence was not found at more than 1 mM (up to 10 mM, data not shown). As shown in Fig. 1 , the maximal expression of recombinants was observed at about 6 h after induction by 5 mM IPTG. Both recombinant congerins were obtained as soluble fractions after sonication of expressed host cells. However, rCon I expressed in JM109 was very low compared with Con II under the same conditions (Fig. 1) . Typical yields of puriˆed rCon I and II after a‹nity chromatography with HCl-treated Sepharose 6B were about 50 mg and 120 mg, respectively, from 1 l of 2×YT medium. This seemed to be caused by the diŠerent frequency of codon usage between E. coli and conger eel because the expression levels increased when the Nterminal region (residues between 1st to 10th) of Con I was replaced by that of Con II or bovine galectin 1 to construct a chimeric mutant (Fig. 2A) .
The diŠerences of nucleotide sequences between Con I and chimera mutant plasmids were the codons for Leu and Val; that is, CTT for Leu and GTC for Val in Con I were changed into CTA and GTT, respectively, in human and bovine galectin 1, (Fig 2A) . Judging from the observation, the usage of these codons seemed to be responsible for the low expression level of rCon I. In order to increase the expression level of rCon I, the codons for Leu4 (CTT) and Val6 (GTC) of rCon I were mutated into CTA and GTT, respectively, without amino acid changes ( Fig. 2A) . Relative amounts of expressed rCon I using pTV-Con I and mutated plasmid vector pTV-Con I-m comparing with that of rCon II (100z) were estimated to be 49z and 97z, respectively, suggesting that the expression increased to the same level as that of rCon II by mutation (Fig. 2B) . The result suggests that the optimization of codon usage for genes is eŠective for improving the expression e‹ciency of recombinant proteins. Makrides reviewed the strategies for achieving high-level expression of proteins in E. coli, and suggested that codon usage was one of the potential impediments to high-level expression of recombinants. 8) To date, several recombinant proteins have been successfully expressed with high-level production by replacement of low-usage codons in E. coli. [9] [10] [11] In fact, we obtained the high-level expression of rCon I by replacing the low-usage codon GTC for Val6 with the high-usage codon GTT. However, other low-usage codons, CTA for Leu4 of Con Im and AGA for Arg3 and Arg7 of Con II, did not have an in‰uence on the expression level in this study, indicating that not only the codons but also the secondary structure of mRNA seemed to be relevant to the expression in E. coli. The distinct secondary structures of Con I RNA and mutated Con I RNA, which were predicted by using GENETIX-SV W RC soft ware (ver. 10. 1. 1) based on minimum free energy, support this assumption (data not shown).
The yields of rCon I and rCon II puriˆed by using a‹nity and anion-exchange chromatography were [A] Coomassie brilliant blue R-250 staining. A portion of an E. coli culture solution (e.g. 50 ml of culture when OD 600 was 1.0) was centrifuged, and put through SDS-PAGE after boiling in 10 ml of sample buŠer.
[B] Western blotting using anti-Con I and anti-Con II antibodies. The expression e‹ciency was estimated from the corresponding protein bands on SDS-PAGE by using an NIH Image, and expressed as relative amount when compared with that of rCon II.
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about 80¿100 mg from a 1-liter culture. This expression yield of congerins was higher than those of other recombinant galectins. For example, Hirabayashi et al‚ reported that recombinant human galectin 1 and their mutants yielded 0.09 mg¿2.0 mg from a 1-liter E. coli culture, 12, 13) and C. elegans recombinant galectins yielded 10¿20 mg from a 1-liter culture. 14) Recently, Faullit et al‚ also reported that the yield of puriˆed recombinant human galectin 1 was 13 mg.
15)
The puriˆcations of rCon I and rCon II from the E. coli extract were done by using a‹nity chromatography on HCl-treated Sepharose 6B and successive anion exchange chromatography on Hi-Trap Q. The puriˆed rCon I and II showed single bands corresponding to approximately 16 kDa on SDS-PAGE, which were the expected size for native Con I and II (data not shown). The puriˆed recombinant proteins were further characterized by analyzing their amino acid sequences, molecular masses, and the interactions with glycoprotein. The N-terminal sequences of rCon I and rCon II were analyzed by a gas-phase protein sequencer (PSQ-10, Shimadzu, Kyoto, Japan) without any pre-treatment to give the same amino acid sequences as native congerins. This indicates that the N-termini of rCon I and rCon II expressed in E. coli were not acetylated diŠerently from native congerins. 1, 3) These results were conˆrmed by mass diŠerence of rCon I (15,455) and native Con I (15,495) measured by matrix-assisted laser desorption ionization time of ‰ight mass spectrometry (Shimadzu), and by peptide mapping with lysylendopeptidase digestion (data not shown). It also suggests that the Met residue at the translational starting site was removed by the intrinsic protease in E. coli.
The hemagglutinating (lectin) activities of recombinant Con I and II were analyzed by using rabbit erythrocytes. The minimum concentrations for hemagglutinating activities of native Con I and rCon I were estimated to be ¿2.0 mg W ml, while those of native Con II and rCon II were ¿4.0 mg W ml. The binding a‹nity of rCon I and rCon II against asialofetuin immobilized onto a CM5 sensor chip was analyzed using the surface plasmon resonance with the BIAcore 1000 system. The KA of rCon I and rCon II were 5.94×10 7 and 1.80×10 7 , respectively, which were in agreement with those of native congerins (4.24×10 7 for Con I and 1.28×10 7 for Con II).
3) Recently, the X-ray crystal structure of native Con I was analyzed, and it was found that Con I adopts a dimer structure by forming the domain-swapping structures at the N-terminal region. 4) rCon I showed quite the same structure in spite of lacking an N-terminal acetyl moiety (data not shown). No other diŠerence was observed in the structures of either native or recombinant Con II. Thus, it is concluded that the acetylated N-termini of congerins were not signiˆcant for their structures and lectin activities.
It is well known that many recombinant proteins of diŠerent origins from E. coli are generally expressed as inclusion bodies. 16) In this study, a highlevel expression system of rCon I and rCon II was successfully constructed. Recombinant Con I and Con II were recovered as soluble fractions as well as other recombinant galectins, [12] [13] [14] [15] although galectins all had a b-sheet structure called jelly-role motifs that seemed to be disadvantageous for their foldings because of their susceptibilities to aggregation, like an amyloid protein. This expression system is useful for mutagenesis study of galectins by site-directed mutagenesis and the directed evolution method, and the structure-function relationship of congerins using these techniques can now be studied.
